Concepedia

Shashank Gorityala

SG

Statistics

Publications

9

Citations

421

H-Index

9

Active since

2016

Affiliations

Case Western Reserve University(Current)

Cleveland State University

Covance (United States)

Sun Yat-sen University

University of Memphis

Shashank Gorityala is an author at Case Western Reserve University specializing in molecular oncology, oncology, and drug delivery.

Publications per year

2016–2022

9

Publications

9

5-Fluorouracil Enhances the Antitumor Activity of the Glutaminase Inhibitor CB-839 against <i>PIK3CA</i> -Mutant Colorectal Cancers

Yiqing Zhao, Xiujing Feng, Yicheng Chen et al. · Cancer Research · 2020 · 140 citations · Full text

Medicine, Oncology, Pharmacology +15

Recent trends in design and evaluation of chitosan-based colon targeted drug delivery systems: Update 2020

Mallesh Kurakula, Shashank Gorityala, Keshav S. Moharir · Journal of Drug Delivery Science and Technology · 2021 · 82 citations

Pharmacy, Pharmaceutics, Pharmacology +17

RNF126 as a Biomarker of a Poor Prognosis in Invasive Breast Cancer and CHEK1 Inhibitor Efficacy in Breast Cancer Cells

Xiaosong Yang, Pan You, Zhaojun Qiu et al. · Clinical Cancer Research · 2018 · 55 citations

Medicine, Molecular Biology, Oncology +17

Targeting radioresistant breast cancer cells by single agent CHK1 inhibitor via enhancing replication stress

Yao Zhang, Jinzhi Lai, Zhanwen Du et al. · Oncotarget · 2016 · 36 citations · Full text

Medicine, Cancer Biology, Oncology +17

Inhibition of uracil DNA glycosylase sensitizes cancer cells to 5-fluorodeoxyuridine through replication fork collapse-induced DNA damage

Yan Yan, Xiangzi Han, Yulan Qing et al. · Oncotarget · 2016 · 31 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

1–5 of 9